Bionano Genomics, Inc. Common Stock (BNGO) is a publicly traded Healthcare sector company. As of July 27, 2026, BNGO trades at $1.11 with a market cap of $12.74M and a P/E ratio of -0.25. BNGO moved +0.00% today. Year to date, BNGO is -26.00%; over the trailing twelve months it is -67.92%. Its 52-week range spans $1.06 to $22.80. Analyst consensus is buy with an average price target of $4.00. Rallies surfaces BNGO's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
1 analysts cover BNGO: 0 strong buy, 1 buy, 0 hold, 0 sell, and 0 strong sell. The consensus rating is buy. The average price target is $4.00.
| Metric | Value |
|---|---|
| Price | $1.11 |
| Market Cap | $12.74M |
| P/E Ratio | -0.25 |
| EPS | $-4.37 |
| Dividend Yield | 0.00% |
| 52-Week High | $22.80 |
| 52-Week Low | $1.06 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $28.74M |
| Net Income | $-31.60M |
| Gross Margin | 46.97% |
1 analysts cover BNGO: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $4.00.